iPSC技术彻底改变了用于癌症治疗的CAR-T细胞疗法
1Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, CA 90095, USA.
Bioengineering (Basel, Switzerland)
|January 24, 2025
概括
诱导多能干细胞 (iPSC) 技术可以克服当前化学抗原受体 (CAR) -T细胞疗法的局限性. 这种方法可以有效地产生临床级的CAR-T细胞,降低成本,并为多名癌症患者提供全基性治疗.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 干细胞生物学 干细胞生物学
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法对各种癌症显示出有效性.
- 目前的自主CAR-T疗法面临的挑战包括高成本,漫长的制造和严格的患者选择.
- 诱导多能干细胞 (iPSCs) 提供了一种潜在的解决方案,通过提供可再生的T细胞来源.
研究的目的:
- 审查当前的癌症治疗方法.
- 评估用于癌症治疗的CAR-T和iPSC技术的整合.
- 评估iPSC衍生的CAR-T细胞的优缺点.
主要方法:
- 关于CAR-T细胞治疗和iPSC技术的现有文献的综述.
- 对iPSC衍生的CAR-T细胞生成和疗效的实验数据的分析.
- 评估制造工艺,成本和临床适用性.
主要成果:
- 通过iPSC技术,可以产生高产量,纯度和强大的CAR-T细胞.
- 来自iPSC的CAR-T细胞显示出有前途的瘤杀伤疗效.
- 这种方法显著减少了制造时间和成本,促进了全原细胞疗法.
结论:
- iPSC技术提供了一种可行的策略,可以克服自主CAR-T细胞治疗的局限性.
- 来自iPSCs的异构CAR-T细胞疗法可能可以治疗多个患者,增加可访问性.
- 这种新的方法对推进癌症治疗模式具有重大前景.
相关概念视频
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:27Tumor Immunotherapy
467
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
467
01:06Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K